Drugs

Category / Pharmaceuticals & Biotech / Drugs

VANC Pharmaceuticals Announces Supplier Letter of Intent With a Western Canadian Pharmacy Chain

Insys Therapeutics to Report Fourth Quarter and Year-End 2014 Results

Abattis, BioCell Product Launch at CannaCon and Update

M Pharmaceutical Inc. Outlines eMosquito Milestones for 2015 and Final Private Placement Closing

Theravance to Report Fourth Quarter and Full Year 2014 Financial Results on February 18, 2015

Merus Labs Announces Record Q1 2015 Results

Global Blood Therapeutics Strengthens Management Team With Addition of Vice President of Program Leadership and Business Strategy

Cytovance Biologics, Inc. to Present at 2015 Bio Manufacturing Summit

Supreme Completes Operational Transition to Ontario

Kadmon Corporation Announces Publication Highlighting Importance of ROCK2 in Autoimmunity

NEW YORK, NY: Review Underscores Therapeutic Potential of ROCK2 Inhibition in Autoimmune Disease ...

GSK and Theravance Announce Start of Phase III Lung Function Study With ''Closed'' Triple Combination Treatment FF/UMEC/VI for COPD

Theravance Announces FDA Advisory Committee to Review BREO(R) ELLIPTA(R) (FF/VI) for Asthma

Global Blood Therapeutics to Present at 17th Annual BIO CEO & Investor Conference

Cleveland BioLabs to Present at 2015 BIO CEO & Investor Conference

Neuronascent Announces Expanded Patent Coverage in US and Russia for Its Alzheimer''s Disease and Down Syndrome Therapeutics

Merus Labs Appoints Geoff Morrow as Vice President, Business Development

Horizon Pharma plc to Participate in Two Conferences in February

Cleveland BioLabs Announces Oncology Clinical Development Update for Entolimod

OSE Pharma Collaboration for Cancer Trial

Genetic Technologies Announces up to 6 New Breast Centres to Begin Offering BREVAGenplus(R)

Page 25 von 64: 1 « .. 24 25 26 27 28 29 30 31 32 33 .. » 64

Drugs

Category / Pharmaceuticals & Biotech / Drugs

VANC Pharmaceuticals Announces Supplier Letter of Intent With a Western Canadian Pharmacy Chain

Insys Therapeutics to Report Fourth Quarter and Year-End 2014 Results

Abattis, BioCell Product Launch at CannaCon and Update

M Pharmaceutical Inc. Outlines eMosquito Milestones for 2015 and Final Private Placement Closing

Theravance to Report Fourth Quarter and Full Year 2014 Financial Results on February 18, 2015

Merus Labs Announces Record Q1 2015 Results

Global Blood Therapeutics Strengthens Management Team With Addition of Vice President of Program Leadership and Business Strategy

Cytovance Biologics, Inc. to Present at 2015 Bio Manufacturing Summit

Supreme Completes Operational Transition to Ontario

Kadmon Corporation Announces Publication Highlighting Importance of ROCK2 in Autoimmunity

GSK and Theravance Announce Start of Phase III Lung Function Study With ''Closed'' Triple Combination Treatment FF/UMEC/VI for COPD

Theravance Announces FDA Advisory Committee to Review BREO(R) ELLIPTA(R) (FF/VI) for Asthma

Global Blood Therapeutics to Present at 17th Annual BIO CEO & Investor Conference

Cleveland BioLabs to Present at 2015 BIO CEO & Investor Conference

Neuronascent Announces Expanded Patent Coverage in US and Russia for Its Alzheimer''s Disease and Down Syndrome Therapeutics

Merus Labs Appoints Geoff Morrow as Vice President, Business Development

Horizon Pharma plc to Participate in Two Conferences in February

Cleveland BioLabs Announces Oncology Clinical Development Update for Entolimod

OSE Pharma Collaboration for Cancer Trial

Genetic Technologies Announces up to 6 New Breast Centres to Begin Offering BREVAGenplus(R)